This is a study to evaluate the safety and effectiveness of Xyrem compared to placebo for the treatment of fibromyalgia. This national study is currently recruiting patients.
Read moreJazz Pharmaceuticals, Inc. announced it has submitted a New Drug Application to the FDA for JZP-6 (sodium oxybate oral solution) for the... Read more »
Last Friday, members of the FDA's Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee overwhelmingly... Read more »
Jazz Pharmaceuticals, Inc. has announced that the FDA's Arthritis Advisory Committee and Drug Safety and Risk Management Advisory Committee... Read more »
A little over a month ago, I told you that an FDA panel had recommended not approving sodium oxybate for fibromyalgia. On October 11, the... Read more »
Since the FDA approval of Lyrica and Cymbalta for the treatment of fibromyalgia, a number of additional medications are also being tested... Read more »
Experts with the U.S. Food and Drug Administration (FDA) have rejected the drug Xyrem (sodium oxybate) as a treatment for fibromyalgia, saying the... Read more »
Source: ADAM Encyclopedia
Overview:The word narcolepsy comes from two Greek words roughly translated as "seized by numbness."Narcolepsy affects around 1 in 2,000 people.The... Read more »
Source: Harvard Decision Guide
Prevention There is no way to prevent narcolepsy. For people who have the condition, avoiding conditions that bring on narcolepsy episodes may help... Read more »
Source: ADAM Encyclopedia
Lifestyle treatment of narcolepsy includes taking three or more scheduled sleep-times/naps throughout the day. Patients should also avoid heavy meals... Read more »
Source: ADAM Encyclopedia
ReferencesCao M. Advances in Narcolepsy. Med Clin N Am. 2010;94:541-555.Dang-Vu TT, Desseilles M, Petit D, Mazza S, Montplaisir J, Maquet P.... Read more »